Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)
| Image |  |
|---|---|
| Description | scientific article published on 01 October 2018 |
| Author/s |
author: Harm van Tinteren Erik van Werkhoven |
| Publication date | October 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |